PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
231.42%
Net income growth 1.25-1.5x CSIQ's 158.41%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
4.76%
D&A growth of 4.76% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-86.46%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
35.15%
SBC growth of 35.15% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
16.52%
Less working capital growth vs. CSIQ's 36.36%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-508.40%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
43.48%
Inventory growth of 43.48% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
319.07%
AP growth of 319.07% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-140.57%
Negative yoy usage while CSIQ is 36.36%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
48.38%
Lower 'other non-cash' growth vs. CSIQ's 126.30%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
57.45%
Operating cash flow growth below 50% of CSIQ's 171.37%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
92.35%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1927.59%
Growth well above CSIQ's 33.39%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
271.13%
Investing outflow well above CSIQ's 4.41%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-356.84%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
29.49%
We have some buyback growth while CSIQ is negative at -13.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.